55KRC: UP-NEXT study tests ovarian cancer treatment
April 13, 2023
The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.
April 13, 2023
The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.
March 13, 2023
The University of Cincinnati's Rhonna Shatz, DO, provided expert commentary to Seasons and MSN about a recent study that found taking sleeping pills could raise the risk of Alzheimer's disease.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.
March 23, 2023
The University of Cincinnati's Erich J. Boomgarden, MD, provided expert analysis of a new Food and Drug Administration policy that will require health care providers to tell women if they have dense breast tissue, a change that could save lives.
March 29, 2023
Neurology Advisor highlighted research from the University of Cincinnati that found rates of infective endocarditis-related stroke in the United States increased with affected patients more likely to be intravenous drug users.
March 28, 2023
Treatment of the first patient in a clinical trial of FLASH proton therapy for cancers in the bones of the chest has been completed at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center.
April 24, 2023
The University of Cincinnati’s Paolo Palmisciano, MD, was part of an award-winning research team that examined how well a minimally invasive approach worked to limit vision and hearing loss in patients following brain tumor surgery and will present the research at the American Association of Neurological Surgeons annual scientific meeting.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
April 27, 2023
National outlets including U.S. News & World Report highlighted research presented by the University of Cincinnati's Alberto Espay on promising new treatments for Parkinson's disease.
April 19, 2023
The University of Cincinnati's Alberto Espay was featured in a MedPage Today article commenting on a recent review that found functional neurological disorder is often misunderstood and needs further recognition and parity in medical education, research and clinical service.